Methodologic approaches for the development of a Canadian best practice statement for the prevention of cardiovascular diseases after a hypertensive disorder of pregnancy

The hypertensive disorders of pregnancy (HDP) are a strong female-specific risk factor for future cardiovascular (CV) diseases. While organizations broadly recommend CV risk factor screening and treatment after HDP, there remains a paucity of evidence to inform specific CV risk factor screening strategies (i.e., timing and cut-offs) and treatments (i.e., thresholds and targets) for this high-risk population. Given the limited direct evidence,...